Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04578938 · ClinicalTrials.gov registry record · Phase 4

Ketamine + Cognitive Training for Suicidality in the Medical Setting

A Phase 4 study of Suicide, Attempted, sponsored by Rebecca Price.

Active
Registry status
Phase 4
Development phase
200
Enrollment target
1
Study location

NCT04578938 is a Phase 4 study of Suicide, Attempted that is active but no longer recruiting, run by Rebecca Price. The registered enrollment target is 200 participants, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04578938, a Phase 4 study of Suicide, Attempted, is active but no longer recruiting, sponsored by Rebecca Price.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.

Conditions Studied

Interventions

  • BEHAVIORAL Sham Training
  • BEHAVIORAL Cognitive training
  • DRUG Intravenous ketamine

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-03-15
Est. Completion 2026-12-02
Phase Phase 4

Sponsor

Rebecca Price

7 total trials

What the Registry Record Tells You About NCT04578938

The ClinicalTrials.gov registry entry for NCT04578938 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower). The listed sponsor is Rebecca Price, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide, Attempted appearing as the primary indexed condition, and to 3 interventions - of which Sham Training is the first listed.

NCT04578938 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04578938 about?

NCT04578938 is a clinical study titled "Ketamine + Cognitive Training for Suicidality in the Medical Setting". This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introd...

What is the current status of trial NCT04578938?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2021-03-15. Estimated completion is 2026-12-02.

What conditions does trial NCT04578938 study?

This clinical trial studies the following conditions: Suicide, Attempted.

What interventions are being tested in trial NCT04578938?

The interventions under investigation include: Sham Training (BEHAVIORAL), Cognitive training (BEHAVIORAL), Intravenous ketamine (DRUG).

Who is sponsoring clinical trial NCT04578938?

This trial is sponsored by Rebecca Price, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04578938 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide, Attempted

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.